Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.

Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y.

Cell Stem Cell. 2008 Feb 7;2(2):141-50. doi: 10.1016/j.stem.2007.11.014.

2.

The interferon signaling network and transcription factor C/EBP-beta.

Li H, Gade P, Xiao W, Kalvakolanu DV.

Cell Mol Immunol. 2007 Dec;4(6):407-18. Review.

3.

TNF-mediated inflammatory disease.

Bradley JR.

J Pathol. 2008 Jan;214(2):149-60. Review.

PMID:
18161752
4.

The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells.

Xu G, Zhang Y, Zhang L, Ren G, Shi Y.

Biochem Biophys Res Commun. 2007 Sep 28;361(3):745-50.

5.
6.
7.

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.

Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, Apparailly F, Cantos C, Jorgensen C, Noël D.

Stem Cells. 2007 Aug;25(8):2025-32.

8.

IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.

English K, Barry FP, Field-Corbett CP, Mahon BP.

Immunol Lett. 2007 Jun 15;110(2):91-100.

PMID:
17507101
9.

Interferon-gamma and NF-kappaB mediate nitric oxide production by mesenchymal stromal cells.

Oh I, Ozaki K, Sato K, Meguro A, Tatara R, Hatanaka K, Nagai T, Muroi K, Ozawa K.

Biochem Biophys Res Commun. 2007 Apr 20;355(4):956-62.

PMID:
17336935
10.

Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.

Xu G, Zhang L, Ren G, Yuan Z, Zhang Y, Zhao RC, Shi Y.

Cell Res. 2007 Mar;17(3):240-8.

11.

From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.

Giordano A, Galderisi U, Marino IR.

J Cell Physiol. 2007 Apr;211(1):27-35. Review.

PMID:
17226788
12.

Immunoregulatory function of mesenchymal stem cells.

Uccelli A, Moretta L, Pistoia V.

Eur J Immunol. 2006 Oct;36(10):2566-73. Review.

13.

C/EBPbeta regulates TNF induced MnSOD expression and protection against apoptosis.

Ranjan P, Boss JM.

Apoptosis. 2006 Oct;11(10):1837-49.

PMID:
16850160
14.

Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma.

Chan JL, Tang KC, Patel AP, Bonilla LM, Pierobon N, Ponzio NM, Rameshwar P.

Blood. 2006 Jun 15;107(12):4817-24.

15.

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S, Annunziato F.

Stem Cells. 2006 Feb;24(2):386-98.

16.

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.

Le Blanc K, Ringdén O.

Biol Blood Marrow Transplant. 2005 May;11(5):321-34. Review.

17.

Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-gamma.

Takami Y, Motoki T, Yamamoto I, Gohda E.

Biochem Biophys Res Commun. 2005 Feb 4;327(1):212-7.

PMID:
15629451
18.

Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.

Proost P, Verpoest S, Van de Borne K, Schutyser E, Struyf S, Put W, Ronsse I, Grillet B, Opdenakker G, Van Damme J.

J Leukoc Biol. 2004 May;75(5):777-84.

PMID:
14996826
20.

Synergistic activation of NF-kappab and inducible isoform of nitric oxide synthase induction by interferon-gamma and tumor necrosis factor-alpha in INS-1 cells.

Sekine N, Ishikawa T, Okazaki T, Hayashi M, Wollheim CB, Fujita T.

J Cell Physiol. 2000 Jul;184(1):46-57.

PMID:
10825233
Items per page

Supplemental Content

Support Center